Cayuga Biotech
Ithaca, United States· Est. 2019
Cayuga Biotech is developing novel therapies to address life-threatening hemorrhage by harnessing the body’s innate ability to stop bleeding.
Private Company
Total funding raised: $25M
About
Cayuga Biotech is developing novel therapies to address life-threatening hemorrhage by harnessing the body’s innate ability to stop bleeding.
Small Molecules
Funding History
2Total raised:$25M
Series A$20MMar 15, 2022
Seed$5MJun 15, 2020